ArticleOncology research2023

PPARα activator irbesartan suppresses the proliferation of endometrial carcinoma cells via SREBP1 and ARID1A.

Y U Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.